Teratogen update: Methylene blue?
1999; Wiley; Volume: 60; Issue: 1 Linguagem: Dinamarquês
10.1002/(sici)1096-9926(199907)60
ISSN2472-1727
Autores Tópico(s)Chemical Analysis and Environmental Impact
ResumoTeratologyVolume 60, Issue 1 p. 42-48 Original Article Teratogen update: Methylene blue†† Janet D. Cragan, Corresponding Author Janet D. Cragan Division of Birth Defects and Developmental Disabilities, National Center for Environmental Health, Centers for Disease Control and Prevention, Public Health Service, U.S. Department of Health and Human Services, Atlanta, Georgia 30333Division of Birth Defects and Developmental Disabilities, MSF45, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Atlanta, GA 30341-3724.Search for more papers by this author Janet D. Cragan, Corresponding Author Janet D. Cragan Division of Birth Defects and Developmental Disabilities, National Center for Environmental Health, Centers for Disease Control and Prevention, Public Health Service, U.S. Department of Health and Human Services, Atlanta, Georgia 30333Division of Birth Defects and Developmental Disabilities, MSF45, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Atlanta, GA 30341-3724.Search for more papers by this author First published: 21 June 1999 https://doi.org/10.1002/(SICI)1096-9926(199907)60:1 3.0.CO;2-ZCitations: 60 † This article is a US government work, and, as such, is in the public domain of the United States of America. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat LITERATURE CITED Abrams JS. 1968. Experimental intestinal atresia. Surgery 64: 185–191. Medline Archer SL, Rist K, Nelson DP, DeMaster EG, Cowan N, Weir EK. 1990. Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs. J Appl Physiol 68: 735–747. Medline Atlay RD, Sutherst JR. 1970. Premature rupture of the fetal membranes confirmed by intraamniotic injection of dye (Evans blue T-1824). Am J Obstet Gynecol 108: 993–994. Medline Barber DA, Rubin JW, Zumbro GL, Tackett RL. 1995. The use of methylene blue as an extravascular surgical marker impairs vascular responses of human saphenous veins. J Thorac Cardiovasc Surg 109: 21–29. Medline Beekhuis JR, De Bruijn HWA, Van Lith JMM, Mantingh A. 1992. Second trimester amniocentesis in twin pregnancies: maternal haemoglobin as a dye marker to differentiate diamniotic twins. Br J Obstet Gynaecol 99: 126–127. Medline Brown G, Frankl D, Phang T. 1996. Continuous infusion of methylene blue for septic shock. Postgrad Med J 72: 612–614. Medline Brüne B, Schmidt KU, Ullrich V. 1990. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur J Biochem 192: 683–688. Medline Canto MIF, Setrakian S, Petras RE, Blades E, Chak A, Sivak MV Jr. 1996. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 44: 1–7. Medline Chang KSK, Zhong MZ, Davis RF. 1996. Indigo carmine inhibits endothelium-dependent and -independent vasodilation. Hypertension 27: 228–234. Medline Chaudhuri G, Buga GM, Gold ME, Wood KS, Ignarro LJ. 1991. Characterization and actions of human umbilical endothelium derived relaxing factor. Br J Pharmacol 102: 31–336. Chitayat D, Ohel G, Marion R, Einarson TR. 1995. Spectrophotometry of amniotic fluid: a simple and rapid method for distinguishing between gestational sacs in second-trimester amniocentesis of twin pregnancies. Obstet Gynecol 86: 569–571. Medline Cowett RM, Hakanson DO, Kocon RW, Oh W. 1976. Untoward neonatal effect of intraamniotic administration of methylene blue. Obstet Gynecol 48: 74–75. Cragan JD, Martin L, Khoury MJ, Fernhoff PM. 1993. Dye use during amniocentesis and birth defects [letter]. Lancet 341: 1352–1353. Medline Cragan JD, Martin L, Waters GD, Khoury MJ. 1994. Increased risk of small intestinal atresia among twins in the United States. Arch Pediatr Adolesc Med 148: 733–739. Medline Crooks J. 1982. Haemolytic jaundice in a neonate after intra-amniotic injection of methylene blue. Arch Dis Child 57: 872–873. Medline Curry S. 1982. Methemoglobinemia. Ann Emerg Med 11: 214–221. Medline Derom AF, Wallaert PC, Janzing HM, Derom E. 1993. Intraoperative identification of parathyroid glands with methylene blue infusion. Am J Surg 165: 380–382. Medline Dolk H. 1991. Methylene blue and atresia or stenosis of ileum and jejunum [letter]. Lancet 338: 1021–1022. Medline Driscoll W, Thurin S, Carrion V, Steinhorn RH, Morin FC III. 1996. Effect of methylene blue on refractory neonatal hypotension. J Pediatr 129: 904–908. Medline Elias S, Gerbie AB, Simpson JL, Nadler HL, Sabbagha RE, Shkolnik A. 1980. Genetic amniocentesis in twin gestations. Am J Obstet Gynecol 138: 169–173. Medline Ellis FD, Seiler JG III, Palmore MM Jr. 1995. Methemoglobinemia: a complication after fiberoptic orotracheal intubation with benzocaine spray. J Bone Joint Surg [Am] 77: 937–939. Medline Erickson JC, Widmer BA. 1968. The vasopressor effect of indigo carmine. Anesthesiology 29: 188–189. Fineman JR, Crowley MR, Heymann MA, Soifer SJ. 1991. In vivo attenuation of endothelium-dependent pulmonary vasodilatation by methylene blue. J Appl Physiol 71: 735–741. Medline Fish WH, Chazen EM. 1992. Toxic effects of methylene blue on the fetus [letter]. Am J Dis Child 146: 1412–1413. Medline Flewellen EH. 1980. Hazards of intravenous indigo carmine, fluorescein, and methylene blue. Tex Med 76: 49–51. Medline Gibson MT, Mangat D, Gagliano G, Wilson M, Fletcher J, Bulman J, Newman HN. 1994. Evaluation of the efficacy of a redox agent in the treatment of chronic periodontitis. J Clin Periodontol 21: 690–700. Medline Glüer S. 1995. Intestinal atresia following intraamniotic use of dyes. Eur J Pediatr Surg 5: 240–242. Medline Goldstein AI, Stills SM. 1983. Midtrimester amniocentesis in twin pregnancies. Obstet Gynecol 62: 659–661. Medline Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro LJ. 1979. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res 5: 211–224. Medline Guttman FM, Braun P, Bensoussan AL, Blanchard H, Desjardins JG, Collin PP. 1975. The pathogenesis of intestinal atresia. Surg Gynecol Obstet 141: 203–206. Medline Hamill PVV. 1997. Re: "Invited commentary: response to science article, 'Epidemiology faces its limits' " [letter]. Am J Epidemiol 146: 527. Medline Hampl V, Tristani-Firouzi M, Weir EK, Huang JMC, Archer SL. 1996. Cyclic guanosine monophosphate as a hyperpolarizing factor. In: PM Vanhoutte, editor. Endothelium-derived hyperpolarizing factor. Amsterdam: Harwood Academic Publishers. p 153–160. Hill AB. 1965. The environment and disease: association or causation? Proc R Soc Med 56: 295–300. Jeanty P, Shah D, Roussis P. 1990. Single-needle insertion on twin amniocentesis. J Ultrasound Med 9: 511–517. Medline Jeffords DL, Lange PH, DeWolf WC. 1977. Severe hypertensive reaction to indigo carmine. Urology 9: 180–181. Medline Jegier W, MacLaurin J, Blankenship W, Lind J. 1964. Comparative study of blood volume estimation in the newborn infant using I131 labeled human serum albumin (IHSA) and T-1824. Scand J Clin Lab Invest 16: 125–132. Katsuki S, Arnold W, Mittal C, Murad F. 1977. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 3: 23–35. Medline Kennedy WF Jr, Wirjoatmadja K, Akamatsu TJ, Bonica JJ. 1968. Cardiovascular and respiratory effects of indigo carmine. J Urol 100: 775–778. Medline Kidd SA, Lancaster PAL, Anderson JC, Boogert A, Fisher CC, Robertson R, Wass DM. 1996. Fetal death after exposure to methylene blue dye during mid-trimester amniocentesis in twin pregnancy. Prenat Diagn 16: 39–47. Medline Kirsch IR, Cohen HJ. 1980. Heinz body hemolytic anemia from the use of methylene blue in neonates. J Pediatr 96: 276–278. Medline Koga Y, Hayashida Y, Ikeda K, Inokuchi K, Hashimoto N. 1975. Intestinal atresia in fetal dogs produced by localized ligation of mesenteric vessels. J Pediatr Surg 10: 949–953. Medline Lancaster PAL, Pedisich EL. 1991. High risk of intestinal atresia among twins born to older mothers [abstract]. Proceedings of the Australian Teratology Society. Lancaster PAL, Pedisich EL, Fisher CC, Robertson RD. 1992. Intra-amniotic methylene blue and intestinal atresia in twins [abstract]. J Perinat Med [Suppl] 20: 262. Lane KL, Vallera R, Washington K, Gottfried MR. 1996. Endoscopic tattoo agents in the colon: tissue responses and clinical implications. Am J Surg Pathol 20: 1266–1270. Medline Lee M, Sharifi R. 1996. Methylene blue versus indigo carmine [letter]. Urology 47: 783–784. Medline Link EM, Costa DC, Lane D, Blower PJ, Spittle MF. 1996. Radioiodinated methylene blue for diagnosing early melanoma metastases [letter]. Lancet 348: 753. Medline Louw JH, Barnard CN. 1955. Congenital intestinal atresia: observations on its origin. Lancet 2: 1065–1066. Luo D, Das S, Vincent SR. 1995. Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase. Eur J Pharmacol 290: 247–251. Medline Manhes H, Shulman A, Haag T, Canis M, Demontmarin JL. 1994. Infertility due to diseased pelvic peritoneum: laparoscopic treatment. Gynecol Obstet Invest 37: 191–195. Medline Marczin N, Ryan US, Catravas JD. 1992. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J Pharmacol Exp Ther 263: 170–179. Medline Marshall JJ, Wei EP, Kontos HA. 1988. Independent blockade of cerebral vasodilation from acetylcholine and nitric oxide. Am J Physiol 255: 847–854. Martin W, Drazan KM, Newby AC. 1989. Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells. Br J Pharmacol 97: 51–56. Medline Mayer B, Brunner F, Schmidt K. 1993. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 45: 367–374. Medline McEnerney JK, McEnerney LN. 1983. Unfavorable neonatal outcome after intraamniotic injection of methylene blue. Obstet Gynecol 61: 35–37. Moncada S, Palmer RMJ, Higgs EA. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142. Medline Moorman-Voestermans CGM, Heij HA, Vos A. 1990. Jejunal atresia in twins. J Pediatr Surg 25: 638–639. Medline Moorman-Voestermans CGM, Heij HA, Vos A. 1992. Letter to the Editor. J Pediatr Surg 27: 133. Medline Myatt L, Brewer A, Brockman DE. 1991. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 164: 687–692. Medline Ng TY, Datta TD, Kirimli BI. 1976. Reaction to indigo carmine. J Urol 116: 132–133. Medline Nicolini U, Monni G. 1990. Intestinal obstruction in babies exposed in utero to methylene blue [letter]. Lancet 336: 1258–1259. Medline Okamura T, Inoue M, Toda N. 1990. Methylene blue-sensitive and -insensitive responses to sodium nitroprusside of blood vessels isolated from animals of different species. Eur J Pharmacol 183: 1267–1268. Orth K, Rück A, Stanescu A, Beger HG. 1995. Intraluminal treatment of inoperable oesophageal tumours by intralesional photodynamic therapy with methylene blue [letter]. Lancet 345: 519–520. Medline Ower PC, Ciantar M, Newman HN, Wilson M, Bulman JS. 1995. The effects on chronic periodontitis of a subgingivally-placed redox agent in a slow release device. J Clin Periodontol 22: 494–500. Medline Plunkett GD. 1973. Neonatal complications [letter]. Obstet Gynecol 41: 476–477. Medline Porat R, Gilbert S, Magilner D. 1996. Methylene blue-induced phototoxicity: An unrecognized complication. Pediatrics 97: 717–721. Medline Preiser JC, Lejeune P, Roman A, Carlier E, De Backer D, Leeman M, Kahn RJ, Vincent JL. 1995. Methylene blue administration in septic shock: A clinical trial. Crit Care Med 23: 259–264. Medline Salaris SC, Babbs CF, Voorhees WD III. 1991. Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. Biochem Pharmacol 42: 499–506. Medline Schneider F, Lutun P, Hasselmann M, Stoclet JC, Tempé JD. 1992. Methylene blue increases systemic vascular resistance in human septic shock. Intensive Care Med 18: 309–311. Medline Serota FT, Bernbaum JC, Schwartz E. 1979. The methylene-blue baby [letter]. Lancet 2: 1142–1143. Medline Shoemaker K, Rubin J, Zumbro GL, Tackett R. 1996. Evans blue and gentian violet: alternatives to methylene blue as a surgical marker dye. J Thorac Cardiovasc Surg 112: 542–544. Medline Sills MR, Zinkham WH. 1994. Methylene blue-induced Heinz body hemolytic anemia. Arch Pediatr Adolesc Med 148: 306–310. Medline Soares-Da-Silva P, Caramona MM. 1988. Effects of methylene blue on the uptake, release and metabolism of noradrenaline in mesenteric arterial vessels. J Pharm Pharmacol 40: 534–538. Medline Spahr RC, Salsburey DJ, Krissberg A, Prin W. 1980. Intraamniotic injection of methylene blue leading to methemoglobinemia in one of twins. Int J Gynaecol Obstet 17: 477–478. Medline Stockand JD, Sansom SC. 1996. Activation by methylene blue of large Ca2+-activated K+ channels. Biochim Biophys Acta 1285: 123–126. Medline Tabsh K. 1990. Genetic amniocentesis in multiple gestation: a new technique to diagnose monoamniotic twins. Obstet Gynecol 75: 296–298. Medline Troche BI. 1989. The methylene blue baby [letter]. N Engl J Med 320: 1756–1757. Medline Van de Voorde J, Vanderstichele H, Leusen I. 1987. Release of endothelium-derived relaxing factor from human umbilical vessels. Circ Res 60: 517–522. Medline Van der Pol JG, Wolf H, Boer K, Treffers PE, Leschot NJ, Hey HA, Vos A. 1992. Jejunal atresia related to the use of methylene blue in genetic amniocentesis in twins. Br J Obstet Gynaecol 99: 141–143. Medline Vincer MJ, Allen AC, Evans JR, Nwaesei C, Stinson DA. 1987. Methylene-blue-induced hemolytic anemia in a neonate. Can Med Assoc J 136: 503–504. White JJ, Esterly JR, Tecklenberg P, Haller JA. 1971. Effect of changing concepts upon the diagnosis and management of intestinal atresia. Am Surg 37: 34–43. Medline Wieding JU, Hellstern P, Köhler M. 1993. Inactivation of viruses in fresh-frozen plasma. Ann Hematol 67: 259–266. Medline Wolf DA, Scheible FW, Young PE, Matson MR. 1979. Genetic amniocentesis in multiple pregnancy. J Clin Ultrasound 7: 208–210. Medline Wolin MS, Cherry PD, Rodenburg JM, Messina EJ, Kaley G. 1990. Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J Pharmacol Exp Ther 254: 872–876. Medline Yallampalli C, Izumi H, Byam-Smith M, Garfield RE. 1994. An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol 170: 175–185. Medline Yang CC, Hwang SF, Chou MM, Deng JF. 1995. Metobrumuron/metachlor ingestion with late onset methemoglobinemia in a pregnant woman successfully treated with methylene blue. J Toxicol Clin Toxicol 33: 713–716. Medline Young JD, Dyar OJ, Xiong L, Zhang J, Gavaghan D. 1994. Effect of methylene blue on the vasodilator action of inhaled nitric oxide in hypoxic sheep. Br J Anaesth 73: 511–516. Medline Young PE, Carson KF, Prichard LL, Jones OW. 1974. A technique for obtaining precise chromosome and bilirubin studies on amniotic fluid in twin pregnancy. J Reprod Med 13: 163–166. Medline Citing Literature Volume60, Issue1July 1999Pages 42-48 ReferencesRelatedInformation
Referência(s)